egfr resisters: an advocacy group - targeted therapies in lung cancer 2023
Published 11 months ago • 31 plays • Length 4:02Download video MP4
Download video MP3
Similar videos
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
2:11
neoadjuvant osimertinib and surgically resectable egfr - targeted therapies in lung cancer 2023
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
4:09
egfr mutations: uncommon treatment & insurance complications -2022 program: targeted therapies forum
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
5:22
egfr tkis and their side effects - 2022 program: targeted therapies forum
-
1:22:21
egfr breakout video targeted therapies 2017
-
7:54
keytruda combined with anti-vegf treatment:use in patients with advanced nsclc-asco lung review 2022
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
5:13
q&a: how do i integrate palliative care services? - targeted therapies in lung cancer 2023
-
5:07
q&a: what is the efficacy of amivantamab and lazertinib? - targeted therapies in lung cancer 2023
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?